A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
Korean Journal of Ophthalmology
;
: 57-59, 2011.
Artículo
en Inglés
| WPRIM
| ID: wpr-121935
ABSTRACT
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Limbo de la Córnea
/
Conjuntiva
/
Enfermedades de la Conjuntiva
/
Inhibidores de la Angiogénesis
/
Inyecciones Intraoculares
/
Hiperplasia
/
Tejido Linfoide
/
Anticuerpos Monoclonales
/
Neovascularización Patológica
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Korean Journal of Ophthalmology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS